agilon health (NYSE:AGL) Coverage Initiated by Analysts at Citigroup

Investment analysts at Citigroup assumed coverage on shares of agilon health (NYSE:AGLGet Free Report) in a research report issued to clients and investors on Monday, Briefing.com reports. The firm set a “neutral” rating and a $6.00 price target on the stock. Citigroup’s price target points to a potential upside of 9.89% from the stock’s current price.

Other analysts have also issued reports about the stock. Jefferies Financial Group reiterated a “hold” rating and set a $6.50 target price (down from $25.00) on shares of agilon health in a report on Monday, February 26th. Benchmark dropped their target price on shares of agilon health from $13.00 to $9.00 and set a “buy” rating for the company in a report on Thursday, February 29th. TD Cowen lowered shares of agilon health from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $12.00 to $6.50 in a report on Monday, February 26th. Stifel Nicolaus dropped their target price on shares of agilon health from $10.00 to $9.00 and set a “hold” rating for the company in a report on Thursday, February 22nd. Finally, Wolfe Research lowered shares of agilon health from an “outperform” rating to a “peer perform” rating in a report on Monday, January 8th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, agilon health has an average rating of “Hold” and a consensus target price of $9.46.

Read Our Latest Report on agilon health

agilon health Stock Performance

NYSE AGL opened at $5.46 on Monday. The company has a 50-day simple moving average of $5.75 and a two-hundred day simple moving average of $9.84. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05. agilon health has a 12-month low of $4.41 and a 12-month high of $26.75. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of -8.40 and a beta of 0.49.

agilon health (NYSE:AGLGet Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The business had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the company earned ($0.14) earnings per share. The business’s quarterly revenue was up 71.8% on a year-over-year basis. On average, equities analysts forecast that agilon health will post -0.35 EPS for the current year.

Hedge Funds Weigh In On agilon health

A number of institutional investors and hedge funds have recently made changes to their positions in the business. First Horizon Advisors Inc. increased its stake in shares of agilon health by 41.2% during the first quarter. First Horizon Advisors Inc. now owns 1,553 shares of the company’s stock valued at $37,000 after purchasing an additional 453 shares in the last quarter. Captrust Financial Advisors increased its stake in shares of agilon health by 1.5% during the fourth quarter. Captrust Financial Advisors now owns 32,971 shares of the company’s stock valued at $532,000 after purchasing an additional 487 shares in the last quarter. Signaturefd LLC increased its stake in shares of agilon health by 73.7% during the third quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock valued at $30,000 after purchasing an additional 710 shares in the last quarter. CWM LLC increased its position in shares of agilon health by 83.7% during the third quarter. CWM LLC now owns 1,585 shares of the company’s stock valued at $28,000 after acquiring an additional 722 shares in the last quarter. Finally, Bailard Inc. increased its position in shares of agilon health by 1.9% during the third quarter. Bailard Inc. now owns 43,752 shares of the company’s stock valued at $777,000 after acquiring an additional 803 shares in the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.